ArticleFuture oncology (London, England)2024

Implementing geriatric assessment for dose optimization of CDK4/6 inhibitors in older breast cancer patients.

Antonis Valachis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.